Efficacy and safety of cilnidipine for the treatment of patients with mild to moderate essential hypertension

Chinese Journal of New Drugs

Volumn 17, Issue 2, 2008, Pages 157-160

  Zhao, Xiu Li ^a   Zhou, Yan Ming ^b   Li, Jie ^a   Xiao, Jie ^a   Wang, Jian Qi ^a   Zhou, Hui ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b Ankang Hospital of Heilongjiang Public Security Agency   (China)

Author keywords

Amlodipine; Cilnidipine; Essential hypertension

Indexed keywords

AMLODIPINE BESYLATE; CILNIDIPINE;

ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; ESSENTIAL HYPERTENSION; HUMAN; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; UNSPECIFIED SIDE EFFECT;

EID: 77953470405     PISSN: 10033734     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. YOSHIMOTO R.DOHMOTO H, YAM ADA K,et al. prolonged inhibition of vascular contraction and calcium influx by the novel 1, 4-dihydropyridine calcium antagonist cilnidipine (FRC-8653) [J]. Jpn J Pharmacol,1991,56(2) : 225-229
2. IKEDA K,HOSONO M,IIDA E,et al. Antihypertensive and cardiovascular profiles of a newly synthesized dihydropyridine derivative 2-methoxyethyl (E)-3- phenyl-2-propen-l - yl(± )-l,4-di-hydro-2, 6-dimethyl^l-(3-nitropheny) pyridine-3, 5- dicarboxy-late (FRC-653) [J]. Pharmacometrics, 1992 ,44 : 433-442.
3. FUJII S, KAMEYAMA K, HAYASHI Y,et al. Effect of cilnidipine, a novel dihydropyridine Ca2+ channel in rat dorsal root ganglion neurons [J]. / Pharmacol Exp Ther, 1997, 280 (3) : 1184-1194.
4. HU DY, ZHAO XL, HE X, et al. A randomized double-blind comparative trial of the efficacy and safety of amlodipine and felodip-ine ER in patients with mild to moderate essential hypertension [J]. Heart Drug,2000,5 :22-26.